103 related articles for article (PubMed ID: 16824809)
1. Peptidomics and proteomics studies of transformed lymphocytes from patients mutated for the eukaryotic initiation factor 2B.
Fogli A; Malinverni C; Thadikkaran L; Combes P; Perret F; Crettaz D; Tissot JD; Boespflug-Tanguy O; Stöcklin R; Bulet P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Aug; 840(1):20-8. PubMed ID: 16824809
[TBL] [Abstract][Full Text] [Related]
2. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
[TBL] [Abstract][Full Text] [Related]
3. Peptidomics analysis of lymphoblastoid cell lines.
Fogli A; Bulet P
Methods Mol Biol; 2010; 615():247-57. PubMed ID: 20013214
[TBL] [Abstract][Full Text] [Related]
4. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the alpha subunit of human translation initiation factor 2B.
Hiyama TB; Ito T; Imataka H; Yokoyama S
J Mol Biol; 2009 Oct; 392(4):937-51. PubMed ID: 19631657
[TBL] [Abstract][Full Text] [Related]
6. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.
van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC
Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887
[TBL] [Abstract][Full Text] [Related]
7. The large spectrum of eIF2B-related diseases.
Fogli A; Boespflug-Tanguy O
Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.
Horzinski L; Kantor L; Huyghe A; Schiffmann R; Elroy-Stein O; Boespflug-Tanguy O; Fogli A
BMC Neurol; 2010 Oct; 10():94. PubMed ID: 20958979
[TBL] [Abstract][Full Text] [Related]
9. Discrimination between stable and dynamic components of protein complexes by means of quantitative proteomics.
Kito K; Kawaguchi N; Okada S; Ito T
Proteomics; 2008 Jun; 8(12):2366-70. PubMed ID: 18563728
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
Horzinski L; Huyghe A; Cardoso MC; Gonthier C; Ouchchane L; Schiffmann R; Blanc P; Boespflug-Tanguy O; Fogli A
PLoS One; 2009 Dec; 4(12):e8318. PubMed ID: 20016818
[TBL] [Abstract][Full Text] [Related]
11. A case of ovarioleukodystrophy without eIF2B mutations.
Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
[TBL] [Abstract][Full Text] [Related]
12. Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis.
Hellin JL; Bech-Serra JJ; Moctezuma EL; Chocron S; Santin S; Madrid A; Vilalta R; Canals F; Torra R; Meseguer A; Nieto JL
Am J Kidney Dis; 2009 Nov; 54(5):871-80. PubMed ID: 19781833
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteome analysis of cisplatin-induced apoptotic Jurkat T cells by stable isotope labeling with amino acids in cell culture, SDS-PAGE, and LC-MALDI-TOF/TOF MS.
Schmidt F; Hustoft HK; Strozynski M; Dimmler C; Rudel T; Thiede B
Electrophoresis; 2007 Dec; 28(23):4359-68. PubMed ID: 17987630
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
15. Off-line two-dimensional liquid chromatography with maximized sample loading to reversed-phase liquid chromatography-electrospray ionization tandem mass spectrometry for shotgun proteome analysis.
Wang N; Xie C; Young JB; Li L
Anal Chem; 2009 Feb; 81(3):1049-60. PubMed ID: 19178338
[TBL] [Abstract][Full Text] [Related]
16. Identification of ten novel mutations in patients with eIF2B-related disorders.
Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
[TBL] [Abstract][Full Text] [Related]
17. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.
Mohammad-Qureshi SS; Jennings MD; Pavitt GD
Biochem Soc Trans; 2008 Aug; 36(Pt 4):658-64. PubMed ID: 18631136
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptidomics: expanding proteomics downwards.
Svensson M; Sköld K; Nilsson A; Fälth M; Svenningsson P; Andrén PE
Biochem Soc Trans; 2007 Jun; 35(Pt 3):588-93. PubMed ID: 17511658
[TBL] [Abstract][Full Text] [Related]
20. Proteomic profiling of endothelial cells in human lung cancer.
Park HJ; Kim BG; Lee SJ; Heo SH; Kim JY; Kwon TH; Lee EB; Ryoo HM; Cho JY
J Proteome Res; 2008 Mar; 7(3):1138-50. PubMed ID: 18220333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
